Treprostinil Injection, Solution
Product Images NDC 0703-0686

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 0703-0686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of treprostinil, showing its molecular framework with hydroxyl groups and aromatic ring, consistent with its identity as the active ingredient in the injection solution by Teva Parenteral Medicines.*

FDA Label Image

Image 2

Kaplan-Meier survival curve chart showing the percentage of subjects without a clinical deterioration event over days on study. It compares Treprostinil treatment versus placebo, indicating better maintenance without deterioration in the Treprostinil group across the study period up to about 56 days, with a reported p-value of 0.000228.*

FDA Label Image

Image 3

Label packaging for Treprostinil Injection 20 mg/20 mL (1 mg/mL) solution for intravenous or subcutaneous infusion. The label indicates a 20 mL multiple dose vial, manufactured by Teva Parenteral Medicines, Inc., with storage instructions and a barcode. The label includes dosing information and manufacturer details including production in Croatia.*

FDA Label Image

Image 4

The image shows the unfolded carton label for Treprostinil Injection 50 mg/20 mL (2.5 mg/mL) by Teva Parenteral Medicines, Inc. It is a 20 mL multiple-dose vial for subcutaneous or intravenous infusion. The label includes dosage information, storage instructions, manufacturer details, and ingredients. The NDC is 0703-0676-01 and the label is dated August 2018.*

FDA Label Image

Image 5

The image shows the carton label for Treprostinil Injection 100 mg/20 mL (5 mg/mL) by Teva Parenteral Medicines, Inc. It is for subcutaneous or intravenous infusion only and comes as a 20 mL multiple dose vial. The label includes dosage instructions, storage conditions, ingredient details, and manufacturing information.*

FDA Label Image

Image 6

Packaging label for Treprostinil Injection 200 mg/20 mL (10 mg/mL) solution, a human prescription drug for subcutaneous or intravenous infusion. The 20 mL multiple dose vial is labeled for use only by prescription and manufactured by Teva Parenteral Medicines, Inc., with production in Croatia. The label includes storage instructions, dosage form, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.